"SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Oct. 31, 2011	Oct. 31, 2010	Oct. 31, 2011	Oct. 31, 2010
Revenues:
Revenues	$ 2,874,189	$ 2,275,210	$ 5,501,240	$ 4,502,226
Revenues - related party	692,981	25,851	914,376	129,390
Total revenues	3,567,170	2,301,061	6,415,616	4,631,616
Cost of revenues	2,876,034	1,875,606	5,360,624	3,667,748
Gross profit	691,136	425,455	1,054,992	963,868
Operating expenses:
Loss on equity investment		28,413		95,967
Loss on disposition of property and equipment	674,675		674,675
Selling expenses	253,314	142,770	402,397	257,298
General and administrative expenses	482,725	736,812	1,734,070	1,441,282
Total operating expenses	1,410,714	907,995	2,811,142	1,794,547
Operating loss	(719,578)	(482,540)	(1,756,150)	(830,679)
Other income:
Gain on change in fair value of derivative liability		3,344		(6,634)
Other (expense) income	(57,080)	2,681	(57,056)	455
Interest income	16,264	8,434	32,493	18,197
Total other income	(40,816)	14,459	(24,563)	25,286
Loss from continuing operations before income taxes and noncontrolling interest	(760,394)	(468,081)	(1,780,713)	(805,393)
Discontinued operations:
Loss from discontinued operations		(444)		(135,736)
Gain on disposal of discontinued operations				11,450
Total loss from discontinued operations		(444)		(124,286)
Loss before income taxes and noncontrolling interest	(760,394)	(468,525)	(1,780,713)	(929,679)
Income taxes		(5,082)		(10,087)
Net loss	(760,394)	(473,607)	(1,780,713)	(939,766)
Less: loss attributable to noncontrolling interest	19,679	30,666	54,258	64,055
Net loss attributable to Sunwin International Neutracueticals, Inc.	(740,715)	(442,941)	(1,726,455)	(875,711)
Comprehensive Income
Net loss	(760,394)	(473,607)	(1,780,713)	(939,766)
Gain on foreign currency translation	379,940	568,981	778,279	852,017
Total Comprehsneive (loss) income	(380,454)	95,374	(1,002,434)	(87,749)
Basic and diluted loss per common share:
Loss from continuing operations	$ 0.00	$ 0.00	$ (0.01)	$ 0.00
Loss from discontinue operations	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Loss per common share	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
Weighted average common shares outstanding - basic and diluted	156,856,137	155,595,888	156,713,593	159,019,533
Amount attributable to Sunwin International Neutracueticals, Inc.
Loss from continuing operations, net of tax	(740,715)	(442,497)	(1,726,455)	(751,425)
Loss from discontinued operations, net of tax		(444)		(124,286)
Net loss attributable to Sunwin International Neutracueticals, Inc.	$ (740,715)	$ (442,941)	$ (1,726,455)	$ (875,711)